CERo Therapeutics Holdings, Inc. (CERO) vs TFF Pharmaceuticals, Inc. (TFFP)

CERo Therapeutics Holdings, Inc. and TFF Pharmaceuticals, Inc. are both Biotechnology companies. TFF Pharmaceuticals, Inc. is the larger, with a market value of $290.0K against $140.0K — 2.1× the size. TFF Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. CERo Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −1,595.0%) and the higher return on invested capital (0.00% vs −2,202.8%). Across the 12 metrics below, CERo Therapeutics Holdings, Inc. leads on 10 and TFF Pharmaceuticals, Inc. on 2.

Valuation

Metric CERO TFFP Biotechnology median
P/E 0.00 n/m 7.88
P/S n/m 0.26 11.47
P/B n/m 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.13 0.74
EV/Sales n/m (1.98) 10.73
Earnings yield 300,221.00% (9,200.00%) (28.84%)
Free cash flow yield (2,869.14%) (4,190.74%) (23.03%)

Profitability

Metric CERO TFFP Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (1,610.76%) 0.00%
Net margin 0.00% (1,595.04%) 0.00%
Free cash flow margin 0.00% (1,084.30%) 0.00%
Return on equity 453.76% (220.13%) (57.72%)
Return on assets (2,352.32%) (168.66%) (49.22%)
Return on invested capital 0.00% (2,202.77%) 0.00%

Growth

Metric CERO TFFP Biotechnology median
Revenue growth (TTM) — 24.54% 5.64%
EPS growth (last fiscal year) 92.12% 55.27% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO TFFP Biotechnology median
Debt to equity (0.02) 0.00 0.00
Current ratio 0.05 0.89 4.73
Net debt to EBITDA 0.10 0.26 0.96

Dividend

Metric CERO TFFP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CERO TFFP Biotechnology median
Market cap 140.00k 290.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack